Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Douglas A. McIntyre | Mar 31, 2009 at 8:54 AM EDT

MS Setback for Acorda (ACOR, BIIB)

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is taking it right on the chin this morning. The company announced that it has…

Douglas A. McIntyre | Feb 14, 2009 at 2:16 PM EST

Carl Icahn Holdings Show No Immunity To Market (IEP, BIIB, AMLN, MOT, YHOO, WMB, APC, TWX, TWC, AMD, TELK, QRCP, LEA, TIN, JCP)

Billionaire and activist investor Carl Icahn has made some large changes to his portfolio holdings. He and Icahn Capital, L.P.…

Douglas A. McIntyre | Feb 6, 2009 at 7:38 AM EST

Carl Icahn Goes After Biogen Idec (BIIB)

Biogen Idec (NASDAQ: BIIB) is coming under fire from activist investor Carl Icahn this morning. A release came out as…

Douglas A. McIntyre | Feb 5, 2009 at 5:57 PM EST

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…

Douglas A. McIntyre | Jan 28, 2009 at 8:40 AM EST

Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)

These are some of the top pre-market downgrades and cautious calls we have seen from Wall Street analysts this Wednesday…

Douglas A. McIntyre | Jan 27, 2009 at 7:21 AM EST

Top Pre-Market Analyst Upgrades (ARMH, BIIB, CAT, CVH, HCBK, LEN, MOH, TTEK)

These are some of the top analyst upgrades and positive research calls we have seen from Wall Street analysts with…

Douglas A. McIntyre | Jan 5, 2009 at 7:36 AM EST

Top 10 Pre-Market Analyst Upgrades & Downgrades (ALTR, AMZN, BCE, BIIB, LEAP, PDLI, CLUB, VAR, AUY)

It is still fairly thin in analyst upgrades and downgrades as this week marks the return of investment banking and…

Douglas A. McIntyre | Jan 5, 2009 at 7:15 AM EST

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…

Douglas A. McIntyre | Dec 15, 2008 at 9:25 AM EST

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Biogen Idec Inc. (NASDAQ: BIIB) just came out with an SEC filing showing that on December 11, 2008, regulatory agencies…

Douglas A. McIntyre | Dec 10, 2008 at 11:04 AM EST

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…

Douglas A. McIntyre | Nov 3, 2008 at 7:38 AM EST

Early Bird Analyst Upgrades (ACOR, BIIB, BKC, CHRT, OSG, SLB, TSO, WMT)

These are some of the top pre-market upgrades from analysts which we have seen in the early hours this Monday…

Douglas A. McIntyre | Oct 29, 2008 at 3:57 PM EDT

Biogen Finds More PML In The Woodpile (BIIB)

Biogen Idec Inc. (NASDAQ: BIIB has notified regulatory agencies of a confirmed case of progressive multifocal leukoencephalopathy (PML) in a…

Douglas A. McIntyre | Sep 25, 2008 at 6:49 AM EDT

Top Analyst Upgrades & Downgrades (BIIB, COWN, MYL, PRX, SMBL, TEVA, CBY, CCL, DLB, JCP, JEF, PRSP)

Below are some of the top analyst calls we are seeing from Wall Street firms this Thursday morning: Biogen Idec…

Douglas A. McIntyre | Sep 11, 2008 at 6:23 AM EDT

Early Bird Pre-Market Analyst Upgrades (ALB, AUXL, BIIB, CBEY, HAIN, HWD, LVS, SYMC, TEVA, TWTC, WBSN, WFMI)

These are some of the early bird analyst upgrades and positive calls we are seeing this Thursday morning with more…

Douglas A. McIntyre | Aug 12, 2008 at 9:47 AM EDT

Carl Icahn Weighed Down By Investments (IEP, BIIB, MOT, YHOO, FDML)

Icahn Enterprises LP (NYSE: IEP) is perhaps known more for its billionaire owner/founder Carl Icahn more than it is for…

1 … 36 37 38 39 40 41

Biogen : BIIB

All Biogen Articles

MS Setback for Acorda (ACOR, BIIB)

Carl Icahn Holdings Show No Immunity To Market (IEP, BIIB, AMLN, MOT, YHOO, WMB, APC, TWX, TWC, AMD, TELK, QRCP, LEA, TIN, JCP)

Carl Icahn Goes After Biogen Idec (BIIB)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)

Top Pre-Market Analyst Upgrades (ARMH, BIIB, CAT, CVH, HCBK, LEN, MOH, TTEK)

Top 10 Pre-Market Analyst Upgrades & Downgrades (ALTR, AMZN, BCE, BIIB, LEAP, PDLI, CLUB, VAR, AUY)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Early Bird Analyst Upgrades (ACOR, BIIB, BKC, CHRT, OSG, SLB, TSO, WMT)

Biogen Finds More PML In The Woodpile (BIIB)

Top Analyst Upgrades & Downgrades (BIIB, COWN, MYL, PRX, SMBL, TEVA, CBY, CCL, DLB, JCP, JEF, PRSP)

Early Bird Pre-Market Analyst Upgrades (ALB, AUXL, BIIB, CBEY, HAIN, HWD, LVS, SYMC, TEVA, TWTC, WBSN, WFMI)

Carl Icahn Weighed Down By Investments (IEP, BIIB, MOT, YHOO, FDML)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Biogen : BIIB

All Biogen Articles

MS Setback for Acorda (ACOR, BIIB)

Carl Icahn Holdings Show No Immunity To Market (IEP, BIIB, AMLN, MOT, YHOO, WMB, APC, TWX, TWC, AMD, TELK, QRCP, LEA, TIN, JCP)

Carl Icahn Goes After Biogen Idec (BIIB)

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Top Pre-Market Analyst Downgrades (AMLN, BIIB, CIEN, XOM, GFA, MXIM, BTU, SLT, SPWRA)

Top Pre-Market Analyst Upgrades (ARMH, BIIB, CAT, CVH, HCBK, LEN, MOH, TTEK)

Top 10 Pre-Market Analyst Upgrades & Downgrades (ALTR, AMZN, BCE, BIIB, LEAP, PDLI, CLUB, VAR, AUY)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Day Trader Alert: Biogen Idec & Another PML Case (BIIB, ELN)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

Early Bird Analyst Upgrades (ACOR, BIIB, BKC, CHRT, OSG, SLB, TSO, WMT)

Biogen Finds More PML In The Woodpile (BIIB)

Top Analyst Upgrades & Downgrades (BIIB, COWN, MYL, PRX, SMBL, TEVA, CBY, CCL, DLB, JCP, JEF, PRSP)

Early Bird Pre-Market Analyst Upgrades (ALB, AUXL, BIIB, CBEY, HAIN, HWD, LVS, SYMC, TEVA, TWTC, WBSN, WFMI)

Carl Icahn Weighed Down By Investments (IEP, BIIB, MOT, YHOO, FDML)

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do